Oncology
2 drugs are in development for Urothelial Cancer.
- Companies
- 2
- Clinical trials
- 24
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Urothelial Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(2)
| Drug | Company |
|---|---|
| CT-202 | Context Therapeutics Inc. (CNTX) |
| STRO-004 | SUTRO BIOPHARMA, INC. (STRO) |
About this indication
Urothelial Cancer context
Oncology·MeSH: Urinary Bladder Neoplasms (D001749)
Narrower concept of MeSH descriptor Urinary Bladder Neoplasms
Frequently asked questions
How many drugs are in development for Urothelial Cancer?
BioSniper tracks 2 drugs in development for Urothelial Cancer across 2 companies.
How many clinical trials target Urothelial Cancer?
There are 24 clinical trials targeting Urothelial Cancer tracked by BioSniper.